The Role of Different Inflammatory Indices in the Diagnosis of COVID-19

References

• Gorbalenya AE, Baker SC, Baric RS, et al. Severe acute respiratory syndrome-related coronavirus: the species and its viruses – a statement of the coronavirus study group. bioRxiv. 2020;2020. doi:10.1101/2020.02.07.937862
   Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-5
   PubMed Web of Science ®Google Scholar
• Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ; HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033–1034. doi:10.1016/S0140-6736(20)30628-0
   PubMed Web of Science ®Google Scholar
• Ciceri F, Beretta L, Scandroglio AM, et al. Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis. Crit Care Resusc. 2020;22(2):95–97.
   PubMed Web of Science ®Google Scholar
• Xiang N, Havers F, Chen T, et al. Use of national pneumonia surveillance to describe influenza A(H7N9) virus epidemiology, China, 2004-2013. Emerg Infect Dis. 2013;19(11):1784–1790. doi:10.3201/eid1911.130865
   PubMed Web of Science ®Google Scholar
• Güneş M, Büyükgöl H. Relationship between generalized epileptic seizure and neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and neutrophil mediated inflammation. Int J Neurosci. 2020;130(11):1095–1100. doi:10.1080/00207454.2020.1722662
   PubMed Web of Science ®Google Scholar
• Qu R, Ling Y, Zhang YH, et al. Platelet-to-lymphocyte ratio is associated with prognosis in patients with coronavirus disease-19. J Med Virol. 2020;92(9):1533–1541. doi:10.1002/jmv.25767
   PubMed Web of Science ®Google Scholar
• Jenne CN, Kubes P. Platelets in inflammation and infection. Platelets. 2015;26(4):286–292. doi:10.3109/09537104.2015.1010441
   PubMed Web of Science ®Google Scholar
• Lazzaroni MG, Piantoni S, Masneri S, et al. Coagulation dysfunction in COVID-19: the interplay between inflammation, viral infection and the coagulation system. Blood Rev. 2021;46:100745. doi:10.1016/j.blre.2020.100745
   PubMed Web of Science ®Google Scholar
• Wool GD, Miller JL. The Impact of COVID-19 disease on platelets and coagulation. Pathobiology. 2021;88(1):15–27. doi:10.1159/000512007
   PubMed Web of Science ®Google Scholar
• Ulinici M, Covantev S, Wingfield-Digby J, Beloukas A, Mathioudakis AG, Corlateanu A. Screening, diagnostic and prognostic tests for COVID-19: a comprehensive review. Life (Basel). 2021;11(6):561.
   PubMed Web of Science ®Google Scholar
• Hong X, Cui B, Wang M, Yang Z, Wang L, Xu Q. Systemic immune-inflammation index, based on platelet counts and neutrophil-lymphocyte ratio, is useful for predicting prognosis in small cell lung cancer. Tohoku J Exp Med. 2015;236(4):297–304. doi:10.1620/tjem.236.297
   PubMed Web of Science ®Google Scholar
• Ying HQ, Deng QW, He BS, et al. Suppressed T cell-mediated immunity in patients with COVID-19: a clinical retrospective study in Wuhan, China. J Infect. 2020;81(1):e51–e60. doi:10.1016/j.jinf.2020.04.012
   Web of Science ®Google Scholar
• Yu H, Yu H, Yu H, et al. Total protein as a biomarker for predicting coronavirus disease-2019 pneumonia. Lancet. 2020;2020:20.
   Google Scholar
• Qin C, Zhou L, Hu Z, et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis. 2020;71:762.
   PubMed Web of Science ®Google Scholar
• Usul E, Şan İ, Bekgöz B, Şahin A. Role of hematological parameters in COVID-19 patients in the emergency room. Biomark Med. 2020;14(13):1207–1215. doi:10.2217/bmm-2020-0317
   PubMed Web of Science ®Google Scholar
• Fois AG, Paliogiannis P, Scano V, et al. The systemic inflammation index on admission predicts in-hospital mortality in COVID-19 patients. Molecules. 2020;25(23):5725. doi:10.3390/molecules25235725
   PubMed Web of Science ®Google Scholar
• Chau VQ, Oliveros E, Mahmood K, et al. The imperfect cytokine storm: severe COVID-19 with ARDS in a patient on durable LVAD support. JACC Case Rep. 2020;2(9):1315–1320. doi:10.1016/j.jaccas.2020.04.001
   PubMedGoogle Scholar
• Cossarizza A, Gibellini L, De Biasi S, et al. Handling and processing of blood specimens from patients with COVID-19 for safe studies on cell phenotype and cytokine storm. Cytometry A. 2020;97(7):668–673. doi:10.1002/cyto.a.24009
   PubMed Web of Science ®Google Scholar
• Ying HQ, Deng QW, He BS, et al. The prognostic value of preoperative NLR, d-NLR, PLR and LMR for predicting clinical outcome in surgical colorectal cancer patients. Medical Oncology. 2014;31(12):305. doi:10.1007/s12032-014-0305-0
   PubMed Web of Science ®Google Scholar
• Acar E, Demir A, Yıldırım B, Kaya MG, Gökçek K. The role of hemogram parameters and C-reactive protein in predicting mortality in COVID-19 infection. Int J Clin Pract. 2021;75(7):e14256. doi:10.1111/ijcp.14256
   PubMed Web of Science ®Google Scholar
• World Health Organization. Clinical Management of Severe Acute Respiratory Infection When Middle East Respiratory Syndrome Coronavirus (MERS-Cov) Infection is Suspected: Interim Guidance. World Health Organization; 2019.
   Google Scholar
• Seyit M, Avci E, Nar R, et al. Neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio and platelet to lymphocyte ratio to predict the severity of COVID-19. Am J Emerg Med. 2021;45:569. doi:10.1016/j.ajem.2020.12.069
   PubMed Web of Science ®Google Scholar
• Sun S, Cai X, Wang H, et al. Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China. Clin Chim Acta. 2020;507:174–180. doi:10.1016/j.cca.2020.04.024
   PubMed Web of Science ®Google Scholar
• Khartabil TA, Russcher H, van der Ven A, de Rijke YB. A summary of the diagnostic and prognostic value of hemocytometry markers in COVID-19 patients. Crit Rev Clin Lab Sci. 2020;57(6):415–431. doi:10.1080/10408363.2020.1774736
   PubMed Web of Science ®Google Scholar
• Feng Z, Yu Q, Yao S, et al. Early prediction of disease progression in 2019 novel coronavirus pneumonia patients outside Wuhan with CT and clinical characteristics. medRxiv. 2020;11:4968.
   Google Scholar
• Yang A, Liu J, Tao W, et al. The diagnostic and predictive role of in COVID-19 patients NLR, d-NLR and PLR. Int Immunopharmacol. 2020;84:106504. doi:10.1016/j.intimp.2020.106504
   PubMed Web of Science ®Google Scholar
• Yang P, Ding Y, Xu Z, et al. Epidemiological and clinical features of COVID-19 patients with and without pneumonia in Beijing, China. medRxiv. 2020. doi:10.1101/2020.02.28.20028068
   Google Scholar
• Song C-Y, Xu J, He J-Q, et al. COVID-19 early warning score: a multi-parameter screening tool to identify highly suspected patients. medRxiv. 2020. doi:10.1101/2020.03.05.20031906
   Google Scholar
• Chandler CM, Reid MC, Cherian S, Sabath DE, Edlefsen KL. Comparison of blood counts and markers of inflammation and coagulation in patients with and without COVID-19 presenting to the Emergency Department in Seattle, WA. Am J Clin Pathol. 2021;156(2):185–197. doi:10.1093/ajcp/aqab052
   PubMed Web of Science ®Google Scholar
• Zhang B, Zhou X, Qiu Y, et al. Clinical characteristics of 82 cases of death from COVID-19. PLoS One. 2020;15(7):e0235458. doi:10.1371/journal.pone.0235458
   PubMed Web of Science ®Google Scholar
• Nalbant A, Demirci T, Kaya T, Aydın A, Altındiş M, Güçlü E. Can prognostic nutritional index and systemic immune-inflammatory index predict disease severity in COVID-19? Int J Clin Pract. 2021;17:e14544.
   Google Scholar
• Carpio-Orantes LD, García-Méndez S, Hernández-Hernández SN. Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and systemic immune-inflammation index in patients with COVID-19-associated pneumonia. Gac Med Mex. 2020;156(6):527–531.
   PubMed Web of Science ®Google Scholar
• Azab B, Camacho-Rivera M, Taioli E. Average values and racial differences of neutrophil lymphocyte ratio among a nationally representative sample of United States subjects. PLoS One. 2014;9(11):e112361. doi:10.1371/journal.pone.0112361
   PubMed Web of Science ®Google Scholar
• Fu L, Wang B, Yuan T, et al. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: a systematic review and meta-analysis. J Infect. 2020;80(6):656–665. doi:10.1016/j.jinf.2020.03.041
   PubMed Web of Science ®Google Scholar
• Du Y, Tu L, Zhu P, et al. Clinical features of 85 fatal cases of COVID-19 from Wuhan. A retrospective observational study. Am J Respir Crit Care Med. 2020;201(11):1372–1379. doi:10.1164/rccm.202003-0543OC
   PubMed Web of Science ®Google Scholar
• Tan L, Wang Q, Zhang D, et al. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Signal Transduct Target Ther. 2020;5(1):33. doi:10.1038/s41392-020-0148-4
   PubMed Web of Science ®Google Scholar
• Lindsley AW, Schwartz JT, Rothenberg ME. Eosinophil responses during COVID-19 infections and coronavirus vaccination. J Allergy Clin Immunol. 2020;146(1):1–7. doi:10.1016/j.jaci.2020.04.021
   PubMed Web of Science ®Google Scholar
• Ai JW, Zhang HC, Xu T, et al. Optimizing diagnostic strategy for novel coronavirus pneumonia, a multi-center study in Eastern China. MedRxiv. 2020. doi:10.1101/2020.02.13.20022673
   PubMedGoogle Scholar
• Lo IL, Lio CF, Cheong HH, et al. Evaluation of SARS-CoV-2 RNA shedding in clinical specimens and clinical characteristics of 10 patients with COVID-19 in Macau. Int J Biol Sci. 2020;16(10):1698–1707. doi:10.7150/ijbs.45357
   PubMed Web of Science ®Google Scholar
• McCranor BJ, Kim MJ, Cruz NM, et al. Interleukin-6 directly impairs the erythroid development of human TF1 erythroleukemic cells. Blood Cells Mol Dis. 2014;52(2–3):126–133. doi:10.1016/j.bcmd.2013.09.004
   PubMed Web of Science ®Google Scholar
• Yang M, Li CK, Li K, et al. Hematological findings in SARS patients and possible mechanisms (review). Int J Mol Med. 2004;14(2):311–315.
   PubMed Web of Science ®Google Scholar
• Hariyanto TI, Kurniawan A. Anemia is associated with severe coronavirus disease 2019 (COVID-19) infection. Transfus Apher Sci. 2020;59(6):102926. doi:10.1016/j.transci.2020.102926
   PubMed Web of Science ®Google Scholar
• Yang M, Chen X, Xu Y, Retrospective A. Study of the C-reactive protein to lymphocyte ratio and disease severity in 108 patients with early COVID-19 pneumonia from January to March 2020 in Wuhan, China. Med Sci Monit. 2020;26:e926393. doi:10.12659/MSM.926393
   PubMed Web of Science ®Google Scholar
• Xu JB, Xu C, Zhang RB, et al. Associations of procalcitonin, C-reaction protein and neutrophil-to-lymphocyte ratio with mortality in hospitalized COVID-19 patients in China. Sci Rep. 2020;10(1):15058. doi:10.1038/s41598-020-72164-7
   PubMed Web of Science ®Google Scholar